Related by context. All words. (Click for frequent words.) 82 Initiative K DOQI 76 Quality Initiative KDOQI 68 K DOQI 68 K DOQI guidelines 66 Levels Linked 66 Chronic Obstructive Lung 65 Dialysis Outcomes 65 hyperphenylalaninemia HPA due 64 reduce serum phosphate 64 ICAEL 64 iPTH 64 Arterial Hypertension 63 hematological parameters 63 Skin sterol 63 Clinical Practice Guidelines 63 KDOQI 63 Thromboembolic 63 Secondary Hyperparathyroidism 63 Laryngeal Cancer 63 chronic thromboembolic pulmonary 63 Hypertriglyceridemia 63 HDL Cholesterol 63 Cystatin C 63 Hyperlipidemia 63 Drug Prevents 63 Arteriosclerosis 63 Disease GOLD 62 Invasive Breast Cancer 62 Chronic Kidney 62 serum phosphate 62 number NCT# ClinicalTrials.gov 62 See CLINICAL PHARMACOLOGY 62 Cardiorespiratory fitness 62 STRIDE PD 62 serum GGT 62 Triglyceride 62 Proteinuria 62 Patient Registry 62 Shows Promise Against 62 unresectable tumors 62 thyrotropin levels 62 echocardiographic parameters 62 Nebulized Formoterol 62 Clinical Guideline 61 atherogenic dyslipidemia 61 Functional Outcomes 61 Genes Identified 61 nonfasting triglyceride levels 61 Renal Insufficiency 61 #-# Full Text 61 Am J Clin 61 lactate dehydrogenase LDH 61 Prostate Cancer Risk 61 urine albumin 61 Nonalcoholic Fatty Liver Disease 61 LDL Cholesterol 61 Acute Liver Failure 61 SHPT 61 Cholesterol Levels SPARCL 61 Inflammatory Markers 61 Atherosclerotic 61 BENECOL R Spreads 61 Microalbuminuria 61 glycosylated hemoglobin HbA1c 61 serum triglycerides 61 Oxidized LDL 61 Clinical Outcome 61 Improves Outcomes 61 worsening thrombocytopenia 61 Treating Chronic 61 Basal Cell 60 Gene Mutation Linked 60 Primary endpoints 60 Chronic HCV 60 Bronchopulmonary Dysplasia 60 Outpatient Setting 60 Chronic Renal Failure 60 Estrogen Receptor 60 Acute Stroke 60 RECIST Response Evaluation Criteria 60 J Am Coll 60 Mortality Risk 60 Lung Injury 60 Tumor Response 60 serum phosphorous 60 journal Circulation Cardiovascular 60 Albuminuria 60 Cardiopulmonary bypass 60 serum glucose 60 hepatocellular carcinoma liver 60 Minimally Invasive Treatment 60 Uncontrolled hypertension 60 Alimentary Tract 60 CTAP# Capsules 60 Muscle Function 60 Renal Function 60 vascular reactivity 60 homocysteine concentrations 60 Lp PLA 2 60 Patients Receiving 60 Thiazolidinediones 60 #:#-#,# Medline 60 Neurologic Disorders 60 Squamous Cell 60 Peritoneal Dialysis 60 NCCN Updates 60 Osteoarthritis Patients 60 mIU L 60 Prognostic Value 60 Solid Tumors 60 Accessed #/#/# [001] 60 FDA Approves Drug 60 Sleep Disturbances 60 Ischemic heart 60 Reduces Mortality 60 Test Detects 60 Cardiotoxicity 60 BEXXAR Therapeutic Regimen 60 ST Segment Elevation 60 oral antidiabetic medication 60 HIV HCV coinfected 60 Chronic Heart Failure 60 Hypertrophy 60 Venous Thromboembolism 60 allogeneic hematopoietic stem cell 60 Rheumatoid Arthritis Patients 60 Heart Transplant Recipients 60 Hemolysis 60 Subgroup Analysis 60 Surgical Outcomes 60 glomerular filtration rate 59 calculated creatinine clearance 59 Recommended Dietary Allowance 59 Treatment Reduces 59 Cardiovascular Outcomes 59 Nonalcoholic fatty liver 59 Severe Asthma 59 gallstone disease 59 J Nutr 59 #:#-#,# CrossRef Medline [002] 59 Nonalcoholic Steatohepatitis 59 elevated uric acid 59 Common Terminology Criteria 59 serum lipid levels 59 Cognitive Function 59 parathyroid carcinoma 59 serum leptin 59 Clinical Practice Guideline 59 Catheter Associated 59 Slows Progression 59 intact parathyroid hormone 59 hemoglobin A1c HbA1c 59 Cognitive Deficits 59 Hyperparathyroidism 59 serum uric acid 59 abdominal adiposity 59 Maven Semantic 59 HbA1C 59 Depressive Symptoms 59 Reduced Risk 59 severe renal insufficiency 59 nonfasting triglycerides 59 Allogeneic 59 Program NCEP 59 Hematological 59 sUA 59 Metabolic Disorder 59 cardiovascular calcification 59 Trandolapril 59 triglyceride concentrations 59 transferrin saturation 59 Prospective Randomized 59 Sleep Disordered Breathing 59 Acute Heart Failure 59 riociguat 59 serum aminotransferase levels 59 Transplant Rejection 59 deCODE AF TM 59 urinary albumin excretion 59 Fecal Incontinence 59 Patient Outcomes 59 elevated fasting glucose 59 AA Amyloidosis 59 Nutrition SACN 59 ANN INTERN MED 59 left ventricular diastolic 59 Non Alcoholic Steatohepatitis 59 Fasting blood glucose 59 PCWP 59 Non Alcoholic Fatty 59 Prolongs Survival 59 thyrotropin 59 Crit Rev 59 calcium phosphorus 59 PLX STROKE targeting 59 prostate carcinogenesis 59 CABG Surgery 59 lupus renal disease 59 arterial calcification 59 Healthbeat Report 59 Renal Failure 59 Immune Tolerance 59 Homocysteine levels 59 pretreatment serum 59 Medication Adherence 59 glycated hemoglobin 59 Preterm Delivery 59 C Reactive Protein 59 total cholesterol triglycerides 59 Treating Prostate Cancer 59 Leslie Spry 59 Protein Linked 59 Bronchiectasis 59 Renal Cell Carcinoma RCC 59 Aggressive Reduction 59 atherothrombotic disease 59 colorectal adenoma 59 aminotransferase 59 Non inferiority 59 Comorbidities 59 Unsaturated fats 59 Rheumatoid 58 non fasting triglycerides 58 Project SCIP 58 Nesiritide 58 eNO 58 NHANES III 58 ACC AHA 58 receiving VELCADE 58 ACE Inhibitor 58 Circulatory Physiology 58 myeloperoxidase 58 percutaneous transluminal coronary angioplasty 58 Homocysteine 58 Obesity Linked 58 Diabetic nephropathy 58 Myoblast 58 Kidney Disease Education 58 Cardiovascular Disease Risk 58 leiomyomas 58 Stop Hypertension DASH diet 58 Warfarin Coumadin 58 prospectively stratified 58 Vitamin D Linked 58 Physical Function 58 Stress Induced 58 NNT = 58 HCV Protease Inhibitor 58 adrenocortical cancer 58 Ischaemic 58 Randomized Controlled Trials 58 pulmonary exacerbations 58 glomerular filtration 58 Mammography Screening 58 pancreas esophagus 58 Stop Hypertension DASH 58 Hormone Refractory Prostate Cancer 58 cholestasis 58 Nephrogenic 58 paroxysmal nocturnal hemoglobinuria 58 ACCF AHA 58 Cell Lymphoma CTCL 58 Free Full Text 58 aspartate aminotransferase AST 58 pretransplant 58 Ovarian Cancers 58 Occlusive Disease 58 Nephrol Dial Transplant 58 SSc 58 Genes Predict 58 Combo Therapy 58 hydroxyvitamin D levels 58 Pemphigus 58 plasma lipids 58 Study Shows Benefits 58 troponin T 58 Hypoglycaemia 58 Dietary Reference Intakes 58 Arch Intern Med 58 Index CDAI 58 renal allograft 58 serum triglyceride levels 58 deCODE ProstateCancer TM 58 Oral Fingolimod 58 Hypercholesterolemia 58 nephrolithiasis 58 Pregnancy Outcomes 58 moderate renal impairment 58 Inhaled Steroids 58 folate vitamin B6 58 Diabetic Retinopathy 58 Dietary Fat 58 #.#mg/dL 58 candesartan cilexetil 58 Coronary artery calcification 58 mL/min/#.# m 2 58 Soluble CD# 58 PSA nadir 58 #:#-# [035] 58 intracranial atherosclerosis 58 Iron Overload 58 Gastric Cancer 58 Hemodialysis Patients 58 microalbumin 58 diabetes dyslipidemia 58 elevated LDL cholesterol 58 Guideline Update 58 Detection Evaluation 58 Diagnostic Accuracy 58 See WARNINGS 58 Angiographic 58 Acute Decompensated Heart Failure 58 Glycemic 58 Endothelial 58 hypercholesterolaemia 58 Outcome Measures 58 plasma renin activity 58 Secondary efficacy endpoints 58 Colposcopy 58 Eur J Endocrinol 58 estimated glomerular filtration 58 circulating endothelial cells 58 Orthostatic Hypotension 58 Am J Epidemiol 58 J Pediatr 58 Primary Hypercholesterolemia 58 atherothrombosis 58 Practice Patterns 58 hyperuricaemia 58 baseline serum creatinine 58 Colorectal Cancers 58 Uterine Fibroid 58 cystic fibrosis chronic pancreatitis 58 macroalbuminuria 58 Outcomes Framework QOF 58 lipoprotein Lp 58 aminotransferase ALT 58 CIMZIA ™ 58 Bone Metastases 57 Atypical Hemolytic Uremic Syndrome 57 Novel Treatments 57 perinatal morbidity 57 Intravenous Immunoglobulin 57 Ann Oncol 57 plasma folate 57 Anticoagulation 57 INSPIRE Trial Phase III 57 hypereosinophilic syndrome 57 angina myocardial infarction 57 Creatinine 57 Smoking Linked 57 Surgical Treatment 57 trigylcerides 57 Prolongs Life 57 PAOD 57 glucose insulin 57 Periodontal Disease 57 Circulatory Support 57 Quality Standards NAAQS 57 acute humoral rejection 57 Echocardiographic 57 Drug Shows Promise 57 Critical Limb Ischemia CLI 57 serum vitamin D 57 Anaemia 57 Hematologic 57 haematologic 57 fats lipids 57 kidney urologic 57 hypercalciuria 57 allogeneic hematopoietic cell 57 Prostate specific antigen 57 Pancreas Transplant 57 Breast Cancer Recurrence 57 Castration Resistant Prostate Cancer 57 atherosclerotic renal artery stenosis 57 Slow Progression 57 metastatic malignant 57 Avandia Actos 57 Naive Patients 57 biostatistical analysis 57 GRNCM1 57 Enteral Nutrition 57 systemic hypotension 57 National Guideline Clearinghouse 57 chronic hemodialysis 57 Diagnostic Criteria 57 cinacalcet 57 Islet Transplantation 57 Septic Shock 57 Lung Cancer Survival 57 autosomal dominant polycystic kidney 57 Diabetes Digestive 57 colesevelam HCl 57 Hepatotoxicity 57 Artery Disease 57 chromium supplementation 57 macrovascular events 57 Heart Failure Patients 57 metabolic syndrome MetS 57 carotid artery intima media 57 emphasizes fruits vegetables 57 Zemplar Capsules 57 thyroid stimulating hormone 57 Recurrent Breast Cancer 57 relapsed MM 57 deCODE BreastCancer 57 Diabetes Physician Recognition 57 Ribavirin causes 57 Visceral Fat 57 thrombocytopenic 57 Postdoctoral Position 57 Polymorphisms 57 Overactive Bladder 57 By JENNIFER LEARN 57 Investigational Treatment 57 asymptomatic hyperuricemia 57 Arteriovenous 57 Initiates Clinical Trial 57 Stop Hypertension diet 57 urate levels 57 Cotinine 57 lipoprotein levels 57 Often Misdiagnosed 57 Antidepressants Linked 57 Chronic renal failure 57 specific antigen PSA 57 Tasigna prolongs 57 hemoglobin A1c 57 #rd Annual CTRC 57 Vitamin D Deficiency 57 DASH Diet 57 cystatin C 57 Improve Diagnosis 57 vitamin B# folic acid 57 Coronary Artery Calcium 57 Glomerular Filtration Rate 57 basal cell nevus syndrome 57 Statin Drugs 57 Autoimmune Diseases 57 NOMID 57 Lowering Blood Pressure 57 glycosylated hemoglobin levels 57 Fibrosis 57 Hp2 2 57 allogeneic bone marrow 57 fasting plasma glucose FPG 57 Response Evaluation Criteria 57 INS# [002] 57 Hb A1C 57 symptomatic intracranial 57 elevated triglycerides 57 HDL LDL 57 hemodilution 57 Cancer Incidence Mortality 57 Therapy Reduces 57 Therapy Improves 57 Fasting glucose 57 immunochemical fecal occult 57 Prostate Cancer Survival 57 Insulin Therapy 57 glycaemia 57 Vidofludimus 57 Knee Osteoarthritis 57 gestational hypertension 57 Clin J 57 myocardial uptake 57 intravascular hemolysis 57 mixed hyperlipidemia 57 Renal dysfunction 57 Acute renal failure 57 #:# -# [004] 57 fasting lipid 57 Systemic Lupus Erythematosus SLE 57 Insulin Levels 57 erythrocyte sedimentation rate 57 Valvular Heart Disease 57 Ocrelizumab 57 chronic idiopathic thrombocytopenic purpura 57 Adiposity 57 Erythropoietic therapies may 57 Subarachnoid hemorrhage 57 Cholesterol Linked 57 Colorectal Cancer Screening 57 Alzheimer disease vascular dementia 57 Demonstrates Sustained 57 Vitamin D Levels 57 secondary hyperparathyroidism 57 Rhinosinusitis 57 soluble CD# ligand 57 Bipolar Disorders 57 MRSA Infections 57 Vaccine Immunology 57 DASH Dietary Approaches 57 Liprotamase 57 Mg Uk 57 Early Diagnosis 57 AST ALT 57 pulmonary arterial 57 Preterm Birth 57 oxidized cysteine 57 systemic corticosteroid 57 CYT# potent vascular disrupting 57 hypercalcaemia 57 HER2 expression 57 #:#-#,# [002] 57 Lung Transplantation 57 morphometric vertebral fractures 57 diabetes hyperlipidemia 57 SGPT 57 ANCA associated 57 Guidelines Issued 57 Colorectal 57 nonalcoholic steatohepatitis NASH 57 Neurological Disorder 57 NYHA functional class 57 fibrin deposition 57 artery stenosis 57 Voluntary Consensus 57 urinary albumin 57 Nutritional Status 57 hydroxy vitamin D 57 GAMMAGARD 57 Strongly Linked 57 postoperative pulmonary 57 dose Iluvien 57 Bone Marrow Transplants 57 congenital toxoplasmosis 57 Dose Response 57 Prognostic Factors 57 Cholesterol Levels 57 preserved ejection fraction 57 Cognitive Impairment 57 vitreous floaters 57 ImmuKnow 57 E selectin 57 colorectal carcinoma 57 Coronary Arteries 57 Causes Symptoms 57 HOMA IR 56 diastolic blood pressures 56 estimated GFR 56 obese postmenopausal 56 lichen planus 56 severe oral mucositis 56 Cardiovascular Magnetic Resonance 56 Follicular Lymphoma 56 serum PTH 56 papillary renal cell carcinoma 56 NCEP ATP III 56 Post Menopausal 56 Disease Specific 56 serum folate concentrations 56 evaluating mipomersen 56 Computed Tomographic 56 Hormone Receptor Positive 56 #:# -# [005] 56 metastatic gastric 56 Coronary Artery Bypass Graft 56 Inhaled Corticosteroids 56 CYP#A# CYP#D# 56 Cardiac Resynchronization 56 Venous Thrombosis 56 Molecular Basis 56 NIASPAN 56 Inhaled Nitric Oxide 56 serum calcium 56 venous thromboembolic disease 56 Pituitary 56 Insulin Sensitivity 56 Stop Hypertension 56 dual endothelin receptor antagonist 56 Calcium intake 56 epoetin alpha 56 Mg Usa 56 Environ Health Perspect 56 Randomized Double blind 56 Solid Tumours 56 Diabetologia 56 ATACAND 56 Glycemic Control 56 mutated K ras 56 MDRD equation 56 pmol L 56 primary aldosteronism 56 metastatic pancreatic 56 μg L 56 Carotid Revascularization Endarterectomy vs. 56 Autoimmune Disease 56 lignan intake 56 hypovitaminosis D 56 hyperhomocysteinemia 56 creatinine ratio 56 stage IIIb IV 56 transfusion syndrome 56 hyperlipidaemia 56 Treatment Shows Promise 56 Leukemias 56 Am J Cardiol 56 Antisoma AS# 56 transient elastography 56 Neoadjuvant Chemotherapy 56 Vigorous Exercise 56 glycated hemoglobin levels 56 urinary calcium 56 rheumatoid arthritis osteoarthritis ankylosing 56 Lymphatic System 56 Investigational Drug 56 endocrinology gastroenterology 56 hemoglobin concentration 56 VEGF induced 56 haematopoietic stem cell 56 Lipid Lowering Treatment 56 aminotransferases 56 Hematopoietic 56 Syncria R 56 gene polymorphisms 56 evaluate ZFP Therapeutic 56 Molecular Cancer 56 metastatic neuroendocrine tumors 56 natriuresis 56 Study AREDS 56 inflammatory biomarkers 56 Histological 56 Hyperphosphatemia 56 Monocyte 56 Erythropoiesis Stimulating Agents 56 Fibromyalgia Pain 56 MPGN 56 3g dietary fiber 56 Quality Indicators 56 journal Arteriosclerosis Thrombosis 56 hyperphosphatemia 56 Prednisone Against Refractory 56 J Allergy Clin 56 Lipid Metabolism 56 malondialdehyde 56 Arch Neurol 56 Oral Anticoagulants 56 hs CRP 56 iron chelators 56 Calcium Vitamin D 56 Heavy menstrual bleeding 56 corneal ectasia 56 Heavy snorers 56 serum parathyroid hormone 56 Circulating Tumor Cells 56 Appropriateness Criteria 56 Hydroxyurea 56 alanine aminotransferase ALT 56 CHAMPION PCI 56 choline intake 56 transcranial Doppler ultrasound 56 Lymphocytic 56 Juvenile Idiopathic Arthritis JIA 56 Acute Ischemic Stroke 56 mesangial 56 dyslipidaemia 56 NCI Cancer 56 Spinal Manipulation 56 intermittent hemodialysis 56 nondiabetic patients 56 Ann Rheum Dis 56 Diabetic Patients 56 Lumbar Spine 56 Refractory Angina 56 Interventional Procedures 56 Genes Discovered 56 AAT deficiency 56 Framework NSF 56 Screening Mammography 56 Prostatic 56 Relapsing Multiple Sclerosis 56 serum selenium 56 Severity Index PASI 56 adiponectin levels 56 cardiac conduction 56 #/#mmHg 56 Diabetic Neuropathy 56 Etanercept 56 BENICAR HCT 56 #:# -# [003] 56 hematologic parameters 56 Gynecological Cancer 56 Thrombolysis 56 CKD MBD 56 CTEPH 56 Successfully Treated 56 Insulin Resistance 56 Histopathological 56 Arthritis Musculoskeletal 56 VLDL cholesterol 56 ptau 56 Urologic Diseases Information 56 cranial irradiation 56 polyp recurrence 56 hemoglobin hematocrit 56 Pervasive Developmental Disorders 56 Hematologic Malignancies 56 pancreatic islet cell 56 Tiotropium 56 symptomatic intracranial hemorrhage 56 Endocrine Practice 56 Thyroid hormone 56 airway hydration 56 Ischemic 56 intestinal mucosal 56 Sociodemographic 56 Clostridium Difficile Associated 56 bronchial hyperresponsiveness 56 prasterone 56 renal failure interstitial lung 56 SGOT 56 serum albumin 56 HES CEL 56 Cervical Cytology 56 GWTG CAD 56 clinicopathological 56 Improved Survival 56 ACE Inhibitors 56 International Prognostic Scoring 56 Darapladib 56 Common Toxicity Criteria 56 Helicobacter pylori infection 56 #:#-#,# CrossRef Medline [001] 56 Opioid Use 56 Keratitis 56 chronic eosinophilic leukemia 56 Diet Linked 56 Cytogenetic 56 liver transplant recipients 56 hepatorenal syndrome 56 Platelet Function 56 NASH Huntington 56 ACCORD Eye 56 LDL HDL 56 Immunohistochemistry 56 Advanced Melanoma 56 N telopeptide 56 albumin excretion rate 56 stem cell engraftment 56 ACTEMRA TM 56 3g saturated 56 Antitumor 56 Specification PAS 56 hemoglobin A1c levels 56 Treating Depression 56 carcinoembryonic antigen 56 postoperative atrial fibrillation 56 #:#-# [007] 56 Kidney Foundations 56 J Am Soc 56 LDL cholesterol HDL cholesterol 56 coronary revascularizations 56 Guidelines Recommend 56 elevated triglyceride levels 56 histologic subtype 56 immunosuppressive regimen 56 LHON 56 Antithrombin 56 #:#-# Abstract Free [009] 56 Diabetes Obesity 56 Reference Dose 56 CINQUIL 56 Efficacy Results 56 tissue oxygenation 56 hay fever allergic rhinitis 56 coagulation abnormalities 56 Cholinesterase Inhibitors 56 Cystectomy 56 DQI 56 REMINYL ® 56 specific IgE 56 Viral load 56 Menopausal Symptoms 56 Practice Guideline 56 myocardial ischaemia 56 Atopic Dermatitis 56 TNF Tumor Necrosis Factor 56 lactate dehydrogenase 56 Therapeutic Efficacy 55 Candesartan 55 fludarabine cyclophosphamide 55 Bloodstream Infections 55 Left Ventricular 55 Pediatric Asthma 55 Bioavailability 55 Peripheral artery disease 55 First Patient Enrolled 55 gastric cardia 55 cardiovascular disease hypertension 55 Arterial stiffness 55 Biologic Therapy 55 bronchopulmonary dysplasia BPD 55 Adult Stem Cell Therapy 55 Thromboembolism 55 Retreatment 55 Carotid Stenting 55 erosive gastritis 55 renal cell carcinomas 55 Alzheimer Disease Cooperative 55 Kidney Int 55 Kidney Function 55 serum potassium 55 metastatic GIST 55 central adiposity 55 serum phosphate levels 55 Shows Efficacy 55 von Willebrand factor 55 triglyceride TG 55 Clostridium difficile Infection 55 serum urate levels 55 β blockers 55 Cardiometabolic 55 umol L 55 Tumor Microenvironment 55 #:#-# [029] 55 Advanced Renal Cell 55 serum lipids 55 triacylglycerol concentrations 55 Hemoglobin A1c 55 inversely associated 55 blood glucose concentrations 55 Chronic Lung 55 Nat Biotechnol 55 mineral density BMD 55 Cholesterol Awareness Month 55 Thiamine 55 moderate hepatic impairment 55 Non Invasive Treatment 55 FASEB J. 55 #:#-#,# [001] 55 EDARBI 55 visit www.lupus.org 55 Cerebrospinal Fluid 55 Oxygen Saturation 55 albiglutide currently 55 YOUR LOCAL ANIMAL SHELTER 55 tryptase 55 Systolic Hypertension 55 overt nephropathy 55 Poorly Controlled 55 microalbuminuria 55 Study Casts Doubt 55 Related Mortality 55 c reactive protein 55 procalcitonin 55 Kidney Transplantation 55 Vasomotor Symptoms 55 Alpha lipoic acid 55 Bone Fractures 55 Breast Cancer Risk 55 doi Abstract Free 55 Pharmacokinetic parameters 55 hemolysis 55 diabetes mellitus DM 55 Renal Artery 55 #mg sodium #mg [002] 55 Acute Treatment 55 abnormal lipid 55 Genetic Diversity 55 antiproliferative effects 55 sFlt 1 55 hemoglobin Hb 55 hepatic cirrhosis 55 included exfoliative dermatitis 55 Galectin 3 55 dilated cardiomyopathy DCM 55 coinfected patients 55 Bronchodilator 55 Better Outcomes 55 serum ferritin 55 graft dysfunction 55 Survivorship Program 55 Hypertension ESH 55 Liver biopsy 55 mU liter 55 GVAX Immunotherapy 55 J Antimicrob Chemother 55 Demonstrate Significant 55 hematopoietic cell 55 Gonadotropin 55 Relapsed Refractory 55 motor neuron degeneration 55 CP CPPS 55 Nutr 55 density lipoprotein HDL cholesterol 55 Psoriasis Area 55 Heart Failure Therapies 55 CIMZIA TM certolizumab pegol 55 Quantitation 55 Vascular Disease Foundation 55 Gastroparesis 55 azilsartan medoxomil 55 mucosal healing 55 induce orthostatic hypotension 55 nicardipine 55 Surgical Procedures 55 Amy Abernethy 55 impaired glucose metabolism 55 stratifying patients 55 access graft VAG 55 Diabetic Eye 55 Health Aff Millwood 55 J Natl Cancer Inst 55 http:/www.diabetes.org 55 angiotensin converting enzyme 55 clinico pathological 55 chronically immunosuppressed solid 55 Chronic Lymphocytic Leukemia 55 SUTENT ® 55 Hazardous Drugs 55 Childhood Immunizations 55 Novel Inhibitor 55 IDDM 55 postoperative mortality 55 5 Fluorouracil 55 valvular heart disease 55 thyroglobulin 55 Newly Diagnosed Patients 55 Myeloproliferative Neoplasms 55 Predict Risk 55 Functional Neurosurgery 55 ADCS CGIC 55 #:#-# [033] 55 bioavailable testosterone 55 atherosclerotic vascular disease 55 Varicose Vein 55 elevated IOP 55 Psychiatric Services #:#-#,# 55 silent myocardial ischemia 55 histopathologic diagnosis 55 Therapy Shows Promise 55 Aortic stenosis 55 Cheson 55 Artificial Pancreas 55 Multiple Sclerosis Rheumatoid Arthritis 55 nonfasting 55 Myoglobin 55 Osteopenia 55 Bucindolol 55 Intervention Trial 55 Sentinel node biopsy 55 Complicated Skin 55 cystoid macular edema 55 Differential Diagnosis 55 Virus Linked 55 nephropathic cystinosis cystinosis 55 vWD 55 Proc Am Soc 55 Consensus Statement 55 Lower Limb 55 Ejection Fraction 55 severe renal impairment 55 #.#mmol L [001] 55 #:#-#,# CrossRef 55 myocardial infarction ventricular fibrillation 55 Asthma COPD 55 Vascugel 55 Docosahexaenoic Acid 55 Lipoprotein 55 Risk Stratification 55 Iron Deficiency Anemia 55 Uterine Fibroid Embolization 55 Oncotype 55 endometrial hyperplasia 55 fasting glucose levels 55 Therapy Evaluation 55 antioxidant supplementation 55 dietary modification 55 Squamous 55 chemoradiation therapy 55 abnormal glucose metabolism 55 serum bilirubin 55 Resistant Hypertension 55 μmol l 55 systemic amyloidosis 55 Preclinical Study 55 Breast Surgeons 55 SIMCOR 55 obesity insulin resistance 55 urinary cortisol 55 Recurrent Stroke 55 plasma lipid 55 plasminogen activator inhibitor 55 pulmonary artery banding 55 Colorectal Adenomas 55 histological subtype 55 Home Hemodialysis 55 Chronic Bronchitis 55 eGFR 55 prospective multicentre 55 purpura ITP 55 glycated hemoglobin HbA1c 55 carotid stenosis 55 tumor histology 55 Sjögren syndrome 55 Blood Glucose 55 HbA 1c